The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm.


Journal

International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 05 02 2021
revised: 05 03 2021
accepted: 05 03 2021
pubmed: 26 3 2021
medline: 27 5 2021
entrez: 25 3 2021
Statut: ppublish

Résumé

The COVID-19 pandemic is a serious global health threat caused by severe acute respiratory syndrome of coronavirus 2 (SARS-CoV-2). Symptoms of COVID-19 are highly variable with common hyperactivity of immune responses known as a "cytokine storm". In fact, this massive release of inflammatory cytokines into in the pulmonary alveolar structure is a main cause of mortality during COVID-19 infection. Current management of COVID-19 is supportive and there is no common clinical protocol applied to suppress this pathological state. Lactoferrin (LF), an iron binding protein, is a first line defense protein that is present in neutrophils and excretory fluids of all mammals, and is well recognized for its role in maturation and regulation of immune system function. Also, due to its ability to sequester free iron, LF is known to protect against insult-induced oxidative stress and subsequent "cytokine storm" that results in dramatic necrosis within the affected tissue. Review of the literature strongly suggests utility of LF to silence the "cytokine storm", giving credence to both prophylactic and therapeutic approaches towards combating COVID-19 infection.

Identifiants

pubmed: 33765614
pii: S1567-5769(21)00207-1
doi: 10.1016/j.intimp.2021.107571
pmc: PMC7953442
pii:
doi:

Substances chimiques

Cytokines 0
Lactoferrin EC 3.4.21.-

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

107571

Subventions

Organisme : NIAID NIH HHS
ID : R42 AI117990
Pays : United States

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Références

Int J Immunopathol Pharmacol. 2015 Dec;28(4):452-68
pubmed: 26315722
Front Mol Biosci. 2021 Feb 15;8:607443
pubmed: 33659275
Int Immunopharmacol. 2014 May;20(1):157-63
pubmed: 24613206
Clin Exp Rheumatol. 2020 Mar-Apr;38(2):337-342
pubmed: 32202240
Nutrients. 2018 Aug 17;10(8):
pubmed: 30126153
Arch Immunol Ther Exp (Warsz). 1999;47(4):257-64
pubmed: 10483875
Inflammation. 2000 Feb;24(1):33-44
pubmed: 10704062
Adv Clin Exp Med. 2018 Mar;27(3):391-399
pubmed: 29533543
Am J Physiol Lung Cell Mol Physiol. 2021 Jan 1;320(1):L12-L16
pubmed: 33050737
J Trauma Acute Care Surg. 2020 May;88(5):579-587
pubmed: 32039976
Molecules. 2020 Nov 16;25(22):
pubmed: 33207753
J Biotechnol. 2013 Dec;168(4):666-75
pubmed: 24070904
Circ Res. 2020 May 8;126(10):1456-1474
pubmed: 32264791
Biochem Cell Biol. 2021 Feb;99(1):73-80
pubmed: 32402212
Clin Exp Immunol. 2018 Jun;192(3):315-324
pubmed: 29393509
Front Immunol. 2017 Nov 06;8:1438
pubmed: 29163511
J Interferon Cytokine Res. 2006 Jul;26(7):489-99
pubmed: 16800788
Biotechnol Genet Eng Rev. 1997;14:303-19
pubmed: 9188157
Postepy Hig Med Dosw (Online). 2007;61:268-76
pubmed: 17507875
J Clin Immunol. 2021 Jan;41(1):11-22
pubmed: 33128665
J Med Virol. 2004 Oct;74(2):262-71
pubmed: 15332275
FEMS Immunol Med Microbiol. 2004 Oct 1;42(2):167-72
pubmed: 15364100
Arch Dis Child. 1992 May;67(5):657-61
pubmed: 1599309
J Pediatr. 2016 Aug;175:68-73.e3
pubmed: 27260839
Nutrients. 2021 Jan 23;13(2):
pubmed: 33498631
Biochem Cell Biol. 2012 Jun;90(3):442-8
pubmed: 22332831
Adv Exp Med Biol. 1994;357:133-41
pubmed: 7762425
Int J Exp Pathol. 1993 Oct;74(5):433-9
pubmed: 8217778
Eur J Biochem. 1993 May 1;213(3):1205-11
pubmed: 8389297
Endocrinology. 2020 Sep 1;161(9):
pubmed: 32730568
Antiviral Res. 2005 Jul;67(1):31-7
pubmed: 15916817
Inflamm Res. 2012 Nov;61(11):1247-55
pubmed: 22810368
Int J Mol Sci. 2019 Sep 23;20(19):
pubmed: 31547574
Virol J. 2010 Nov 19;7:330
pubmed: 21092081
Clin Exp Immunol. 2002 Oct;130(1):25-31
pubmed: 12296849
J Pediatr. 2016 Jun;173 Suppl:S10-5
pubmed: 27234406
Anticancer Res. 2004 Nov-Dec;24(6):3831-6
pubmed: 15736418
Jpn J Med Sci Biol. 1994 Apr;47(2):73-85
pubmed: 7853749
Biometals. 2014 Oct;27(5):1057-68
pubmed: 24842100
Hepatol Res. 2002 Nov;24(3):228
pubmed: 12393024
Mediators Inflamm. 2015;2015:409596
pubmed: 26788020
Front Pediatr. 2018 Jul 19;6:199
pubmed: 30073156
PLoS One. 2011;6(8):e23710
pubmed: 21887302
Postepy Hig Med Dosw (Online). 2007;61:283-7
pubmed: 17507877
Nutr Cancer. 2000;38(2):192-9
pubmed: 11525597
Biol Pharm Bull. 2008 Apr;31(4):569-73
pubmed: 18379042
Lett Appl Microbiol. 2020 Sep;71(3):229-234
pubmed: 32495940
Arch Immunol Ther Exp (Warsz). 2002;50(6):399-410
pubmed: 12546066
Med Microbiol Immunol. 1997 Oct;186(2-3):83-91
pubmed: 9403835
JAMA. 2009 Oct 7;302(13):1421-8
pubmed: 19809023
Nutrients. 2018 Sep 04;10(9):
pubmed: 30181493
Ital J Pediatr. 2021 Feb 15;47(1):32
pubmed: 33588905
Biochem Biophys Res Commun. 2013 May 17;434(4):791-6
pubmed: 23603257
J Med Microbiol. 2005 Aug;54(Pt 8):717-723
pubmed: 16014423
Front Pharmacol. 2020 Aug 07;11:1186
pubmed: 32848789
Biochem Cell Biol. 2012 Jun;90(3):233-44
pubmed: 22540735
Cell Mol Life Sci. 2005 Nov;62(22):2549-59
pubmed: 16261255
J Immunol. 2008 May 15;180(10):6868-76
pubmed: 18453607
Biochem Cell Biol. 2017 Feb;95(1):148-154
pubmed: 28165282
J Trop Pediatr. 2015 Oct;61(5):370-6
pubmed: 26224129
J Pharm Pharmacol. 2006 May;58(5):575-84
pubmed: 16640825
Eur J Clin Nutr. 2003 Dec;57(12):1579-85
pubmed: 14647223
J Biol Chem. 1987 Jan 5;262(1):59-62
pubmed: 3025217
Int Immunopharmacol. 2012 Feb;12(2):460-4
pubmed: 22251871
Arch Immunol Ther Exp (Warsz). 1998;46(3):169-76
pubmed: 9704149
Int J Hyg Environ Health. 2020 Sep;230:113605
pubmed: 32898838
J Antimicrob Chemother. 2018 Dec 1;73(12):3391-3397
pubmed: 30219825
Arch Immunol Ther Exp (Warsz). 1998;46(2):97-104
pubmed: 9613707
Biochem Cell Biol. 2012 Jun;90(3):329-38
pubmed: 22292499
Biochimie. 2009 Jan;91(1):30-4
pubmed: 18472012
Front Cell Infect Microbiol. 2020 Dec 09;10:575559
pubmed: 33363049
Tuberculosis (Edinb). 2011 Dec;91 Suppl 1:S105-13
pubmed: 22138562
Clin Chem Lab Med. 1999 Mar;37(3):281-6
pubmed: 10353473
Exp Ther Med. 2020 Dec;20(6):272
pubmed: 33199997
Int Immunopharmacol. 2005 Mar;5(3):591-9
pubmed: 15683854
Annu Rev Nutr. 1995;15:93-110
pubmed: 8527233
Immunity. 2020 Jul 14;53(1):19-25
pubmed: 32610079
Biochem Cell Biol. 2021 Feb;99(1):1-6
pubmed: 32830532
Cochrane Database Syst Rev. 2017 Jun 28;6:CD007137
pubmed: 28658720
Biochem Cell Biol. 2017 Feb;95(1):41-47
pubmed: 28129511
Biochem Biophys Res Commun. 2015 Nov 27;467(4):766-70
pubmed: 26478433
Am J Perinatol. 2019 Jul;36(S 02):S120-S125
pubmed: 31238372
Lab Invest. 2014 Nov;94(11):1188-99
pubmed: 25068657
Int J Antimicrob Agents. 2020 Sep;56(3):106118
pubmed: 32738305
Pediatr Res. 2007 Jan;61(1):89-92
pubmed: 17211147
Transl Res. 2010 Oct;156(4):207-15
pubmed: 20875896
Nutr Res. 2012 Jul;32(7):503-13
pubmed: 22901558
Int Immunopharmacol. 2013 Feb;15(2):227-31
pubmed: 23267765
Cardiol Rev. 2021 Jan/Feb;29(1):43-47
pubmed: 32947478
Am J Emerg Med. 2008 Jul;26(6):711-5
pubmed: 18606328
Dig Liver Dis. 2020 Dec;52(12):1383-1389
pubmed: 33023827
J Infect Chemother. 2014 Nov;20(11):666-71
pubmed: 25182867
Biometals. 2004 Jun;17(3):225-9
pubmed: 15222469
Innate Immun. 2010 Apr;16(2):67-79
pubmed: 19723832
Biochem Cell Biol. 2021 Feb;99(1):47-53
pubmed: 32476452
Am J Perinatol. 2014 Dec;31(12):1111-20
pubmed: 24839144
Early Hum Dev. 2010 Jul;86 Suppl 1:59-61
pubmed: 20138718
Curr Pharm Des. 2009;15(17):1956-73
pubmed: 19519436
Gene. 1997 Dec 19;204(1-2):171-6
pubmed: 9434181
Pol J Microbiol. 2017 Mar 30;66(1):131-134
pubmed: 29359700
Allergy. 2020 Jul;75(7):1564-1581
pubmed: 32396996
J Am Coll Nutr. 2002 Jun;21(3 Suppl):218S-221S
pubmed: 12071308
Chest. 1998 Mar;113(3 Suppl):224S-227S
pubmed: 9515897
Health Technol Assess. 2018 Dec;22(74):1-60
pubmed: 30574860
Arch Immunol Ther Exp (Warsz). 1997;45(2-3):169-75
pubmed: 9597083
Emerg Microbes Infect. 2021 Dec;10(1):317-330
pubmed: 33560940
Microorganisms. 2020 Oct 01;8(10):
pubmed: 33019592
Virol J. 2013 Jun 19;10:199
pubmed: 23782993
Pathog Glob Health. 2020 Jul;114(5):234-235
pubmed: 32529963
J Med Virol. 2003 Apr;69(4):495-502
pubmed: 12601757
PeerJ. 2020 Nov 02;8:e10322
pubmed: 33194450
Transgenic Res. 2005 Jun;14(3):237-49
pubmed: 16145832
Med Microbiol Immunol. 2007 Sep;196(3):171-80
pubmed: 17377816
Medicine (Baltimore). 2018 Aug;97(35):e11976
pubmed: 30170397
Cell Mol Life Sci. 2005 Nov;62(22):2576-87
pubmed: 16261253
PLoS One. 2011;6(7):e22504
pubmed: 21799877
Pediatr Infect Dis J. 2015 Jun;34(6):571-6
pubmed: 25973934
Biometals. 2010 Jun;23(3):365-76
pubmed: 20143251
J Exp Ther Oncol. 2007;6(2):89-106
pubmed: 17407968
Ann Rheum Dis. 2020 Oct;79(10):1277-1285
pubmed: 32620597
Emerg Microbes Infect. 2020 Dec;9(1):2169-2179
pubmed: 32969768
Radiother Oncol. 2020 Jun;147:212-216
pubmed: 32437820
Biochimie. 2009 Jan;91(1):19-29
pubmed: 18573312
Postepy Hig Med Dosw. 2003;57(4):377-404
pubmed: 14601250
Acta Pharmacol Sin. 2014 May;35(5):557-66
pubmed: 24786230
J Virol. 2014 Nov;88(22):13221-30
pubmed: 25187545
S Afr Med J. 2020 Jul 16;110(8):759-760
pubmed: 32880303
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Nutrients. 2020 Aug 24;12(9):
pubmed: 32847014
Am J Perinatol. 2013 Feb;30(2):105-12
pubmed: 23297181
Immunology. 1995 Sep;86(1):122-7
pubmed: 7590872
Front Pharmacol. 2020 Dec 11;11:602999
pubmed: 33362557
Molecules. 2011 Aug 16;16(8):6992-7018
pubmed: 21847071
Postepy Hig Med Dosw (Online). 2007;61:261-7
pubmed: 17507874
Hua Xi Kou Qiang Yi Xue Za Zhi. 2014 Apr;32(2):166-70
pubmed: 24881213

Auteurs

Michał Zimecki (M)

The Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.

Jeffrey K Actor (JK)

University of Texas, Health Science Center Houston, Texas, USA. Electronic address: Jeffrey.K.Actor@uth.tmc.edu.

Marian L Kruzel (ML)

University of Texas, Health Science Center Houston, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH